Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alex Therapeutics has developed clinically validated, AI-powered digital therapeutics—primarily using cognitive behavioral therapy—for conditions including nicotine addiction and mental health comorbidities. Its smoking cessation app has reached over tens of thousands of users internationally, with positive clinical results reported. A pivotal US study on their anxiety-in-pulmonary-fibrosis program launched recently. The company partners with major pharma companies to co-develop indication-specific SaMDs that are reimbursable under healthcare systems like Germany’s DiGA.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alex Therapeutics.